The first-ever trial of an Ebola vaccine in Africa shows promising initial results, according to a report in the Lancet medical journal.
Scientists say it is a crucial step as other vaccines have shown lower levels of protection in African populations.
Tests involving Ugandan and American volunteers reveal the vaccine is so far safe and generates an immune response in both populations.
It provides reassurance for other trials currently underway, they say.
The Ebola virus has killed more than 6,900 people in the worst-affected countries of Sierra Leone, Liberia and Guinea.
No proven vaccine exists to prevent people from getting the disease, though several trials are underway.
The aim of a successful vaccine is to train the immune systems of healthy people to produce antibodies – proteins capable of fighting off any future infections.
Researchers from the National Institutes of Health tested this experimental vaccine on healthy adults in Uganda, having first trialled it in the United States.
Dr Julie Ledgerwood, the lead researcher, said: "This is the first study to show comparable safety and immune response of an experimental Ebola vaccine in an African population.
"This is particularly encouraging because those at greatest risk of Ebola live primarily in Africa and diminished vaccine protection in African populations has been seen for other diseases."
According to the study some 57% of people in Uganda who received the Ebola vaccine alone developed antibodies against Ebola in their blood.
Dr Sridhar of the University of Oxford, commenting on the research, said the data provided reassurance about separate Ebola virus vaccines trials currently underway in Mali, the US and the UK.
But further tests would be needed to see if the antibodies are strong enough and long-lasting enough to provide adequate protection against the disease.
- Man arrested for threatening to release nude videos of late brother’s wife
- ‘I’m extremely regretful’ – KiDi apologises for ‘inappropriate and unkind’ old tweets
- T Bills, short-term securities will not be affected by Ghana’s debt restructuring – US-based Associate Professor
- Every single day Akufo-Addo remains President, the country drifts into peril – Dr Amoako Baah
- Land acquisition: Here is what you missed on Joy FM’s Super Morning Show
- Pastor jailed for life after planning coup and black genocide
- My husband left me for a ‘sugar mummy’ after 9 months of marriage – Woman shares experience
- We will still be a prime supplier of Mercedes-Benz services in Ghana – Silver Star
- 2 sustain gunshot wounds at mining firm in Samreboi
- SIM re-registration: National Security has warned Akufo-Addo against blockage – Deputy Minority Chief Whip
- Afghan blast kills 19 teenagers sitting practice exam
- Edmund Addo returns to Sheriff Tiraspol after botched summer transfer
- Chinese employer who allegedly slashed throat of Ghanaian employee to be arraigned today
- Elikem Asenath Naa Obiorkor Commey
- State TV off-air amid gunfire in Burkina Faso
- King Charles III: New coins featuring monarch’s portrait unveiled
- Africa’s biotechnology heroes celebrated on OFAB Day
- Queen Elizabeth II died of “old age” – Death certificate reveals
- Uganda gives green light to organ transplants
- Peace deal’ signed by Nigerian presidential rivals
- $100m of Ghana’s oil money unaccounted for – Minority raises alarm
- Mozambique police urges ‘knives and machetes’ war on jihadists
- Mankessim murder: Accused persons allegedly confess to killing 3 more people
- From Eric’s Diary: Why the deadline for SIM re-registration will be extended
- Cedi depreciation may force marginal increase in price of petrol, LPG from October 1, 2022